DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Neopap is a drug marketed by Polymedica and is included in one NDA.
The generic ingredient in NEOPAP is acetaminophen. There are sixty-six drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.
A generic version of NEOPAP was approved as acetaminophen by PERRIGO on February 25th, 2000.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Polymedica||NEOPAP||acetaminophen||SUPPOSITORY;RECTAL||016401-001||Approved Prior to Jan 1, 1982||OTC||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|